Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, signaling a new version of the ClinicalTrials.gov record.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's Revision tag was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This is a metadata update and does not modify study content or details.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now shows a new Revision: v3.6.4, replacing the previous v3.6.3, indicating a platform update rather than a change to study information.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision identifier was updated from v3.6.2 to v3.6.3, indicating a small backend update; no visible study details or functionality appear changed.SummaryDifference0.0%

- Check75 days agoChange DetectedA newer site revision label, Revision: v3.6.2, appears on the page, replacing the previous v3.6.0. This indicates a software update to the site's interface rather than a change to the study details or content.SummaryDifference0.0%

- Check89 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was updated; a recruitment notice 'No longer looking for participants' was added. The page version label was updated from Revision: v3.5.5 to Revision: v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.